Literature DB >> 29404756

Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.

Thomas H F Whitfield1,2, Steven A John1, H Jonathon Rendina1,2,3, Christian Grov4, Jeffrey T Parsons5,6,7.   

Abstract

Literature concerning pre-exposure prophylaxis (PrEP) among gay and bisexual identifying men (GBM) has explored facilitators and barriers to uptake and adherence. Far less reported are the reasons why GBM discontinue PrEP use. A national sample of 1071 GBM completed surveys about PrEP use and discontinuation. Participants who were still taking PrEP the 24-month follow up were compared to those that had stopped. Eighteen percent (n = 31) of GBM who reported ever using PrEP discontinued use. Younger (AOR = 0.96; 95% CI 0.92-1.00), and unemployed (AOR = 4.58; 95% CI 1.43-14.70) GBM were more likely to discontinue PrEP than their counterparts. Those that discontinued provided details on why via a free response question. The most common reasons for discontinuation were lower perceived HIV risk (50%) and cost/insurance (30%). Reasons for potential re-initiation included higher-risk sexual activities and changes to structural related barriers. More research is needed to inform interventions on how GBM can continue taking PrEP during changes to employment that effect insurance coverage and cost.

Entities:  

Keywords:  Gay and bisexual men; HIV prevention; Medication discontinuation; Pre-exposure prophylaxis (PrEP); Sexual risk perception

Mesh:

Year:  2018        PMID: 29404756      PMCID: PMC6077114          DOI: 10.1007/s10461-018-2045-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  33 in total

Review 1.  Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence.

Authors:  Ilan H Meyer
Journal:  Psychol Bull       Date:  2003-09       Impact factor: 17.737

2.  Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men.

Authors:  Martin Holt; Dean A Murphy; Denton Callander; Jeanne Ellard; Marsha Rosengarten; Susan C Kippax; John B F de Wit
Journal:  Sex Transm Infect       Date:  2012-01-30       Impact factor: 3.519

Review 3.  Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Authors:  Jared M Baeten; Jessica E Haberer; Albert Y Liu; Nirupama Sista
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

4.  Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.

Authors:  Jeffrey T Parsons; H Jonathon Rendina; Jonathan M Lassiter; Thomas H F Whitfield; Tyrel J Starks; Christian Grov
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

5.  Recruiting a U.S. national sample of HIV-negative gay and bisexual men to complete at-home self-administered HIV/STI testing and surveys: Challenges and Opportunities.

Authors:  Christian Grov; Demetria Cain; Thomas H F Whitfield; H Jonathon Rendina; Mark Pawson; Ana Ventuneac; Jeffrey T Parsons
Journal:  Sex Res Social Policy       Date:  2016-03-01

6.  Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.

Authors:  Kathrine Meyers; Kristina Rodriguez; Atrina L Brill; Yumeng Wu; Melissa La Mar; Debora Dunbar; Beryl Koblin; David Margolis; Magdalena E Sobieszczyk; Hong Van Tieu; Ian Frank; Martin Markowitz; Sarit A Golub
Journal:  AIDS Behav       Date:  2018-04

7.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

8.  Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples.

Authors:  Sarah T Roberts; Renee Heffron; Kenneth Ngure; Connie Celum; Ann Kurth; Kathryn Curran; Nelly Mugo; Jared M Baeten
Journal:  AIDS Behav       Date:  2014-09

9.  Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM).

Authors:  Steven A Elsesser; Catherine E Oldenburg; Katie B Biello; Matthew J Mimiaga; Steven A Safren; James E Egan; David S Novak; Douglas S Krakower; Ron Stall; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2016-07

10.  High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.

Authors:  Kathrine Meyers; Kristina Rodriguez; Robert W Moeller; Ilana Gratch; Martin Markowitz; Perry N Halkitis
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

View more
  64 in total

Review 1.  Implementation Strategies to Increase PrEP Uptake in the South.

Authors:  Patrick S Sullivan; Leandro Mena; Latesha Elopre; Aaron J Siegler
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

2.  Next-Generation Preexposure Prophylaxis: Choices For Effective HIV Prevention.

Authors:  Kenneth K Mugwanya; Jared M Baeten
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

3.  Decisional Balance and Contemplation Ladder to Support Interventions for HIV Pre-Exposure Prophylaxis Uptake and Persistence.

Authors:  Steven A John; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Patient Care STDS       Date:  2019-01-17       Impact factor: 5.078

4.  Demographic, Behavioral, and Geographic Differences Between Men, Transmen, and Transwomen Currently on PrEP, Former PrEP Users, and Those Having Never Used PrEP.

Authors:  Drew A Westmoreland; David W Pantalone; Viraj V Patel; Donald Hoover; Denis Nash; Christian Grov
Journal:  AIDS Behav       Date:  2020-05

5.  Use of Rapid HIV Self-Test to Screen Potential Sexual Partners: Results of the ISUM Study.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Iván C Balán; William Brown; Curtis Dolezal; Cheng-Shiun Leu; Javier Lopez Rios; Alan Z Sheinfil; Timothy Frasca; Christine Tagliaferri Rael; Cody Lentz; Raynier Crespo; Sarah Iribarren; Catherine Cruz Torres; Irma Febo
Journal:  AIDS Behav       Date:  2020-06

6.  Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men Who Have Sex With Men.

Authors:  Lisa A Eaton; Derrick D Matthews; Leigh A Bukowski; M Ruvel Friedman; Cristian J Chandler; Darren L Whitfield; Jordan M Sang; Ron D Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

7.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Authors:  Patrick S Sullivan; Robertino Mera Giler; Farah Mouhanna; Elizabeth S Pembleton; Jodie L Guest; Jeb Jones; Amanda D Castel; Howa Yeung; Michael Kramer; Scott McCallister; Aaron J Siegler
Journal:  Ann Epidemiol       Date:  2018-06-22       Impact factor: 3.797

8.  Insurance- and medical provider-related barriers and facilitators to staying on PrEP: results from a qualitative study.

Authors:  Alexa B D'Angelo; Javier Lopez-Rios; Anthony W P Flynn; Ian W Holloway; David W Pantalone; Christian Grov
Journal:  Transl Behav Med       Date:  2021-03-16       Impact factor: 3.046

9.  Perceptions of PrEP Use Within Primary Relationships Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men.

Authors:  Katherine G Quinn; Meagan Zarwell; Steven A John; Erika Christenson; Jennifer L Walsh
Journal:  Arch Sex Behav       Date:  2020-04-02

Review 10.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.